Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Respiratory and Critical Care Medicine|October 6, 2001
Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthmaS J Wilson, A Wallin, G Della-Cioppa, et al.
European Journal of Clinical Pharmacology|June 17, 1998
The extrapulmonary effects of increasing doses of formoterol in patients with asthmaC Burgess, M Ayson, S Rajasingham, et al.
Maturitas|November 1, 1996
Lack of microbial proliferation and phototoxic potential of a new matrix patch for estradiol deliveryG K Mulberry, G Della-Cioppa, G Monza, et al.
Bio/Technology (Nature Publishing Company)|July 1, 1990
Melanin production in Escherichia coli from a cloned tyrosinase geneG della-Cioppa, S J Garger, G G Sverlow, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 1995
Cytoplasmic inhibition of carotenoid biosynthesis with virus-derived RNAM H Kumagai, J Donson, G della-Cioppa, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 24, 2001
A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhalerG Bensch, R J Lapidus, B E Levine, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Translocation of the precursor of 5-enolpyruvylshikimate-3-phosphate synthase into chloroplasts of higher plants in vitroG Della-Cioppa, S C Bauer, B K Klein, et al.
International Journal of Clinical Practice|June 23, 2004
FEV1 reversibility does not adequately predict effect of formoterol via Aerolizer in chronic obstructive pulmonary diseaseJ F Muir, D Benhamou, A Cuvelier, et al.
The Journal of Allergy and Clinical Immunology|March 9, 1999
Sustained bronchoprotection, bronchodilatation, and symptom control during regular formoterol use in asthma of moderate or greater severity. The Canadian FO/OD1 Study GroupJ M FitzGerald, K R Chapman, G Della Cioppa, et al.
The European Respiratory Journal|September 1, 2001
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmaticsM Solèr, J Matz, R Townley, et al.
Pageof 4